B

BeOne

Global oncology therapeutics discovery, development, manufacturing

Director, Global Value, Access & Pricing, Solid Tumors Pipeline - Multiple Teams

Corporate StrategyConfirmed live in the last 24 hours
Full-timeRemote in USA$183.7k - $243.7k /yr

About the Job

Requirements

  • A BA/BS degree and more than 10 years of related pharmaceutical experience, including at least five years of direct experience in global, regional, or local market access functions.
  • Deep experience in oncology market access and payer engagement, including developing and delivering value toolkits for regional and affiliate teams.
  • Detailed understanding of the global pricing and reimbursement landscape, including regional pricing guidelines, health technology assessment, and national reimbursement processes and requirements.
  • Strong understanding of regional pricing requirements for coverage and reimbursement, with the ability to manage complex cases and address customer objections and questions.
  • Ability to work and communicate across multiple cultures and functions and levels.
  • Analytical ability to structure complex issues, synthesize key points, and communicate and present them clearly.
  • Strategic thinking, initiative, organization, prioritization, and planning skills.
  • Fluency in written and spoken English; a second language is advantageous.
  • Strong customer focus in cross-functional collaboration and teams, with leadership and presentation skills across commercial and finance colleagues.
  • Written and oral communication skills, including synthesizing, interpreting, and translating data into clear commercial strategies and plans.
  • Expertise in dynamic global market access value models, including value-based propositions and cost-effectiveness models.
  • Ability to execute projects promptly.

Responsibilities

  • Develop global pricing and market access strategies for solid-tumor pipeline products, typically including Phase II and III assets, aligned with clinical and commercial goals.
  • Collaborate cross-functionally to integrate access requirements into development, influencing trial design, endpoints, and evidence generation to meet payer needs.
  • Collect and aggregate feedback from regions where the company operates and recommend clinical development and other evidence generation based on that feedback.
  • Represent the Global Value, Access & Pricing Solid Tumors perspective, aligned with regions or focus markets and Health Economics & Outcomes Research, to company governance or oversight bodies.
  • Develop early value propositions for global payers to support future pricing, reimbursement, and access decisions.
  • Work with Clinical, Medical Affairs, and Health Economics & Outcomes Research teams to shape trial design and evidence-generation strategies around target market access requirements.
  • Identify and prioritize evidence gaps; work with Health Economics & Outcomes Research to develop health economic models, burden-of-illness studies, and other data addressing payer concerns and product differentiation.
  • If delegated by the Executive Director, serve as the primary market access point of contact for one or more Global Product Teams.
  • Collaborate with Research & Development, Commercial, Medical Affairs, and Regulatory Affairs to integrate access insights and payer needs into development strategy.
  • Provide input to clinical decisions and Business Development so payer requirements are recognized and addressed, and additional evidence is generated where needed to support commercial strategy.
  • Engage with focus markets and regional access teams to align early on access strategies and support local adaptation.
  • Align with commercial, clinical, medical, Health Economics & Outcomes Research, and regional market access teams on early target product profiles, evidence requirements, and value propositions that support positioning and reduce pricing and reimbursement uncertainty across regions.
  • Drive pre-launch planning for pipeline products, including early value toolkits, Joint Clinical Assessment-relevant PICO development, and early engagement strategies.
  • Support market access launch readiness through communication, training, and support for regional and affiliate teams preparing to engage with payers.
  • Support regional activities related to in-licensing early pipeline products.
  • Monitor the solid-tumor landscape, including competitor activity, evolving payer requirements, and regulatory changes affecting access and reimbursement.
  • Analyze payer insights, pricing trends, and market conditions to inform strategy adjustments and refine access plans.
  • Use global and regional insights to refine value propositions and product positioning as products advance through clinical phases.
  • Lead early pipeline payer consultation processes across regions, in collaboration with regions or focus markets, including with CADTH and NICE.
  • Confer with the Executive Director, Global Value, Access & Pricing Solid Tumors Lead, to determine how and when to disseminate analysis and recommendations.
  • Support portfolio prioritization exercises.

Desired Qualifications

  • An MA/MS degree or higher is preferred.
  • Experience in pipeline or early development and Joint Clinical Assessment preparation is advantageous.
  • Knowledge of health technology assessment methods or health economics modeling is advantageous.
  • A second language is advantageous.

About the Company

BeOne

Global oncology therapeutics discovery, development, manufacturing

BeOne Medicines discovers, develops, and commercializes oncology therapies worldwide, focusing on hematologic cancers and solid tumors. Its products work by leveraging internal R&D and clinical development to bring therapies to market quickly, with Brukinsa serving as a leading backbone in the US and European markets. It differentiates itself through a large-scale global clinical network and cost-efficient development and manufacturing that support high margins and a focus on large-market cancer indications. Its goal is to expand access to high-impact, affordable cancer treatments across more than 45 countries while growing its pipeline into immunology and solid tumors.

Company size
1,001-5,000
Company stage
IPO
Headquarters
Dongcheng District, China
Founded
2010

Recently Posted Jobs

Explore more opportunities at BeOne

See more jobs